SII | Zee News

Advertisement

SII News

Cyrus Poonawalla

16 Jul 2023

Cyrus Poonawalla: The Son Of A Horse Breeder Who Carved His Own Path

Cyrus Poonawalla founded the Serum Institute of India (SII) in 1966, which is today the world's largest vaccine manufacturer.

09 Jan 2023

Covid situation in India better than elsewhere: SII CEO Adar Poonawalla

Covid-19 In India: India is in a better position to tackle the Covid crisis because of the government, healthcare workers and a common goal to tame the virus, said SII CEO Adar Poonawalla.

World Health Organization

01 Nov 2022

'XBB variant may cause new Covid-19 wave': WHO warns as Indians ditch booster

"There are over 300 subvariants of Omicron. I think the one that is concerning right now is XBB, which is a recombinant virus. We had seen some recombinant viruses earlier. It is very immune-evasive, which means it can overcome the antibodies. So slightly that we may see another wave of infections in some countries because of XBB," WHO said.

01 Nov 2022

People fed up of Covid-19 pandemic, no takers for booster jabs: SII CEO

"Since December 2021, we have stopped the production of the Covishield vaccine. We had a stock of a few hundred million doses at that time and of that 100 million doses had already expired," Poonawalla said.

26 Jul 2022

Good news! SII in talks with Novovax to develop vaccine against monkeypox

SII is in talks with Novovax to develop a vaccine against monkeypox This has been confirmed by SII CEO Adar Poonawalla He said that SII is working with Novovax to develop a messenger RNA for monkeypox

Serum Institute of India

24 May 2022

Serum Institute planning to set up its 1st manufacturing plant in Africa

Serum Institute of India is considering setting up its first manufacturing plant in Africa World`s biggest vaccine maker looks to expand globally after its success in selling Covid-19 shots. 'It`s never been a better time to be a vaccine manufacturer,' SII CEO Adar Poonawalla said at the World Economic Forum.

COVID-19 coronavirus

05 May 2022

Covovax available for everyone above age of 12 years: SII CEO Adar Poonawalla

Adar Poonawalla clarified that the Covid-19 vaccine Covovax is available for everyone above the age of 12 years. Earlier, on Tuesday, SII CEO had informed that Covovax (Novavax) is now available for children in India.

03 May 2022

Fourth wave: SII slashes price of each dose of Covovax jab, check details

SII has slashed the price of each dose of Covovax The price of each dose anti-Covid jab has been slashed from Rs 900 to Rs 225 SII CEO has said that Covovax is now available for children in India

29 Apr 2022

NTAGI approves SII's covid vaccine Covovax for 12-17 age group: Sources

The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, as per ANI.

04 Apr 2022

Fourth wave of Covid-19 to hit India? Here's what SII CEO Adar Poonawalla says

Speaking to reporters on the sidelines of the ‘Alternate Fuel Conclave’, the SII CEO said the reason behind the low number of Covid-19 cases at the moment is that the country chose the right vaccine.

23 Mar 2022

Novovax Covid-19 vaccine gets EUA nod for those aged between 12-18 yrs

According to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of India (SII) under the brand name Covovax and is the first protein-based vaccine authorized for use in this age group in India.

09 Mar 2022

SII's ‘Covovax’ gets emergency use nod for children aged above 12 years

"Novavax in global trials has demonstrated more than 90 per cent efficacy. Serum Institute of India`s brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly," SII CEO Adar Poonawala said in a tweet.

15 Dec 2021

'SII working to develop COVID-19 booster shot more effective against Omicron'

SII Chief Executive Officer Adar Poonawalla said COVID vaccines for children aged above 3 years will be launched in the next 6 months.

COVID-19 booster shot

02 Dec 2021

SII seeks approval for Covishield vaccine as booster dose amid Omicron scare

The Serum Institute of India is the first Indian company to seek approval for the COVID-19 booster dose. The new Omicron variant was first reported to the WHO by South Africa on November 24.

28 Nov 2021

Covovax not approved in country of origin yet: Govt panel tells SII

The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.

21 Nov 2021

SII requests Centre to fast-track movement of increasing Covishield stock

SII has urged the Centre to fast-track movement of Covishield domestically and globally. SII can export 50 Lakh doses of Covishield under COVAX.

19 Nov 2021

India allows export of 20 million Novavax COVID vaccine doses to Indonesia

The government has also decided to allow the export of 10 million doses of a licensed version of the AstraZeneca shot made by SII, branded Covishield, to the global vaccine-sharing programme COVAX, two sources said.

18 Nov 2021

Vaccine hesitancy in India greatest threat in overcoming COVID pandemic: SII

Adar Poonawalla’s family-owned company SII is preparing to resume exports to the COVAX international vaccine sharing program for the first time since April.

21 Aug 2021

Serum Institute files for WHO Emergency Use Listing for its Covovax vaccine

Serum Institute of India has filed for WHO emergency use listing for its upcoming COVID vaccine Covovax. The WHO has accepted the application of the Pune-based pharmaceutical company. A pre-submission meeting was also held on August 10.

Serum Institute

29 Jul 2021

Seized COVID vaccine vials not Covishield: Serum Institute to Kolkata Police

Serum Institute has communicated to Kolkata Police that the seized vials with labels of Covishield vaccine in the fake vaccine case in Kolkata was not Covishield vaccine. For further examination, Kolkata Police has sent those vials to Drug Controller for chemical examination.

Loading...

NEWS ON ONE CLICK